Theravance Story

Theravance Inc -- USA Stock  

USD 9.81  9.81  9,223,372,036,855%

Macroaxis does not monitor all media channels or aggregates social signals for Theravance. But even though we do not provide professional-grade financial sentiment analysis on Theravance Inc, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Theravance. Also please take a look at World Market Map.
Glaxo-Innoviva Triple Combo Inhaler Positive in Phase III
GlaxoSmithKline plc GSK and partner Innoviva, Inc. INVA announced that its once-daily single inhaler triple therapy - Trelegy Ellipta - met primary endpoint in a phase III IMPACT study, showing ... GSK and Innoviva Report Positive Headline Results from IMPACT Study Showing ... - Business Wire Theravance Biopharma Highlights Positive Headline Results from IMPACT Study of ... - Markets Insider

Read More...   

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for Theravance

few hours ago at 
As Verizon Communications Share Price Declined, Shareholder Narwhal Capital Management Lowered Holding ...
BZ WeeklyBaupost Group Has Lowered Stake in Avis Budget Group by 112.60 Million as Shares Declined Tjx Cos New ... Bibeypost.comFull coverage
over a month ago at 
In Play Stock Characteristics Innoviva Inc
U.S. stocks posted the biggest drop of this young year after the 10-year treasury yield shot higher, raising concerns higher interest rates would snuff out the bull market.
over two months ago at 
Schroder Investment Management Group Takes 731000 Position in Innoviva Inc
StockNewsTimesMunicipal Employees Retirement System of Michigan Raises Holdings in Innoviva Inc The Lincolnian OnlineGSA Capital Partners LLP Takes Position in Innoviva Inc Dispatch TribunalFull coverage
over three months ago at 
Technical Analysis in Focus Innoviva, Inc.,
Innoviva, Inc., was trading -9.82 percent away from its yearly high level, during the last trading session. The last session volume was 846,097 compared to its average daily volume of 953.17K shares.

Did you try this?

Run Portfolio Manager Now

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
Hide  View All  NextLaunch Portfolio Manager

Cash Flow from Operations

Cash Flow from Operations Comparative Analysis
  Cash Flow from Operations 
      Theravance Comparables 
Theravance is currently under evaluation in cash flow from operations category among related companies. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investor or analyst to check on the quality of a company earnings.